Cargando…

Effects of the N/L‐Type Calcium Channel Blocker Cilnidipine on Nephropathy and Uric Acid Metabolism in Hypertensive Patients With Chronic Kidney Disease (J‐CIRCLE Study)

This study assessed the urinary albumin/creatinine ratio (ACR) and uric acid metabolism in 70 hypertensive patients with chronic kidney disease in whom urinary ACR had remained ≥30 mg/g under the treatment of the L‐type calcium channel blocker amlodipine. Three months after switching to the N/L‐type...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uchida, Shunya, Takahashi, Masato, Sugawara, Masahiro, Saito, Tomoaki, Nakai, Kazuhiko, Fujita, Masami, Mochizuki, Koichi, Shin, Isu, Morita, Takashi, Hikita, Tomoyuki, Itakura, Hironao, Takahashi, Yuko, Mizuno, Shigeki, Ohno, Yasumi, Ito, Kageki, Ito, Takafumi, Soma, Masayoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2014
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031925/ https://www.ncbi.nlm.nih.gov/pubmed/25264215 http://dx.doi.org/10.1111/jch.12412

Ejemplares similares

Effects of Cilnidipine on Heart Rate and Uric Acid Metabolism in Patients With Essential Hypertension
por: Das, Arijit, et al.
Publicado: (2016)

Preparation and evaluation of cilnidipine microemulsion
por: Tandel, Hemal, et al.
Publicado: (2012)

Cilnidipine induced ankle edema
por: Annil, Vishal R., et al.
Publicado: (2014)

Inhibition of Contractility of Isolated Caprine Detrusor by the Calcium Channel Blocker Cilnidipine and Reversal by Calcium Channel Openers
por: Maria, Steffi A., et al.
Publicado: (2023)

Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth
por: Gopinath, Sameera, et al.
Publicado: (2019)

Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats
por: Aritomi, Shizuka, et al.
Publicado: (2015)

Excellent Tolerance to Cilnidipine in Hypertensives with Amlodipine - Induced Edema
por: Shetty, Ranjan, et al.
Publicado: (2013)

Efficacy of Cilnidipine (L/N-type Calcium Channel Blocker) in Treatment of Hypertension: A Meta-Analysis of Randomized and Non-randomized Controlled Trials
por: Chakraborty, Rabindra Nath, et al.
Publicado: (2021)

Renal Function in Hypertensive Patients Receiving Cilnidipine and L-Type Calcium Channel Blockers: A Meta-Analysis of Randomized Controlled and Retrospective Studies
por: Srivathsan, Mayakalyani, et al.
Publicado: (2022)

Serum Triglyceride Lowering Effect of Cilnidipine in Patients With Essential Hypertension
por: Kumar, Prakash, et al.
Publicado: (2016)

Effects of Cilnidipine, an L/N-Type Calcium Channel Blocker, on Carotid Atherosclerosis in Japanese Post-Stroke Hypertensive Patients: Results from the CA-ATTEND Study
por: Nezu, Tomohisa, et al.
Publicado: (2018)

Additive effects of cilnidipine, an L-/N-type calcium channel blocker, and an angiotensin II receptor blocker on reducing cardiorenal damage in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes mellitus
por: Mori, Yutaka, et al.
Publicado: (2014)

Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers
por: Lee, Jieon, et al.
Publicado: (2014)

Comparative effects of valsartan plus cilnidipine or hydrochlorothiazide on nocturnal home blood pressure
por: Fujiwara, Takeshi, et al.
Publicado: (2021)

Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats
por: Takai, Shinji, et al.
Publicado: (2013)

L/N-Type Calcium Channel Blocker Cilnidipine Added to Renin-Angiotensin Inhibition Improves Ambulatory Blood Pressure Profile and Suppresses Cardiac Hypertrophy in Hypertension with Chronic Kidney Disease
por: Kanaoka, Tomohiko, et al.
Publicado: (2013)

Reduction of microalbuminuria in type-2 diabetes mellitus with angiotensin-converting enzyme inhibitor alone and with cilnidipine
por: Singh, V. K., et al.
Publicado: (2015)

Cilnidipine lowered psychological stress-induced increase in blood pressure in a hypertensive man: a case report
por: Hayashida, Sota, et al.
Publicado: (2007)

Cilnidipine and magnesium sulfate supplement ameliorates hyperglycemia, dyslipidemia and inhibits oxidative-stress in fructose-induced diabetic rats
por: Khatun Kali, Most. Sumaiya, et al.
Publicado: (2021)

Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: A prospective study
por: Adake, Prabhakar, et al.
Publicado: (2015)

Chemical inducer of regucalcin attenuates lipopolysaccharide‐induced inflammatory responses in pancreatic MIN6 β‐cells and RAW264.7 macrophages
por: Murata, Tomiyasu, et al.
Publicado: (2021)

Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study
por: Nishida, Yayoi, et al.
Publicado: (2013)

Single‐pill combination of cilnidipine, an l‐/n‐type calcium channel blocker, and valsartan reduces the day‐by‐day variability of morning home systolic blood pressure in patients with treated hypertension: A sub‐analysis of the HOPE‐combi survey
por: Kario, Kazuomi, et al.
Publicado: (2021)

Incidental discovery of circle contact lens by MRI: you can’t scan my poker face, circle contact lens as a potential MRI hazard
por: Tokue, Hiroyuki, et al.
Publicado: (2013)

Comparison of effects of cilnidipine and azelnidipine on blood pressure, heart rate and albuminuria in type 2 diabetics with hypertension: A pilot study
por: Abe, Hiroko, et al.
Publicado: (2012)

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis
por: Tanaka, Yoshimi, et al.
Publicado: (2017)

Circles /
por: Pedoe, Daniel
Publicado: (1957)

The Circle
por: Quammen, David
Publicado: (2014)

Serum uric acid and the incidence of CKD and hypertension
por: Kuriyama, Satoru, et al.
Publicado: (2015)

T/L-type calcium channel blocker reduces the composite ranking of relative risk according to new KDIGO guidelines in patients with chronic kidney disease
por: Abe, Masanori, et al.
Publicado: (2013)

Urinary stones resembling uric acid stones
por: Tanemoto, Masayuki, et al.
Publicado: (2010)

Baseline uric acid levels and steady-state favipiravir concentrations are associated with occurrence of hyperuricemia among COVID-19 patients
por: Koseki, Takenao, et al.
Publicado: (2022)

A Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine
por: Dalal, Jamshed, et al.
Publicado: (2022)

Blood Pressure Reducing Potential and Renoprotective Action of Cilnidipine Among Hypertensive Patients Suffering From Chronic Kidney Disease: A Meta-Analysis
por: Kumari, Kusum, et al.
Publicado: (2023)

Effect of Switching to Azilsartan From Fixed-Dose Combination of an Angiotensin II Receptor Blocker and Calcium Channel Blocker or a Thiazide in Patients With Hypertension
por: Miyoshi, Toru, et al.
Publicado: (2019)

A cell model in the ventral visual pathway for the detection of circles of curvature constituting figures
por: Kawakami, Susumu, et al.
Publicado: (2020)

A Novel Role of Spred2 in the Colonic Epithelial Cell Homeostasis and Inflammation
por: Takahashi, Sakuma, et al.
Publicado: (2016)

Plasma-stimulated medium kills TRAIL-resistant human malignant cells by promoting caspase-independent cell death via membrane potential and calcium dynamics modulation
por: Tokunaga, Tomohiko, et al.
Publicado: (2018)

Rolling Circle Translation of Circular RNA in Living Human Cells
por: Abe, Naoko, et al.
Publicado: (2015)

Circle of friends /
por: Binchy, Maeve
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_7e181itt6q1p0kp42lbgthgfh7